title: Beneficial effects of HLA-DR3 gene expression on renal allograft survival in black recipients.
abstract: We have shown that there is a subgroup of black recipients who lack DR3 antigen expression and have decreased graft survival in comparison to black recipients who express DR3 antigen. Overall, the 3-year renal graft survival was equivalent between white and black recipients in our series and white recipients were not affected by DR3 antigen expression. We suspect that altered immune activity in the DR3-positive black patients may afford a benefit in overcoming immunologic barriers. This needs further investigation both in light of the possible association of the linked antigens A1-Cw7-B8-DR3 which are associated with loss of suppressor cell activity, as well as the issue of DR3 subtyping. However, there clearly exists the possibility of targeting higher risk groups such as the DR3-negative black recipients for more intense immunosuppressive regimens as well as eliminating pretransplant transfusion of third-party donors. Finally, we must reconsider the question of whether HLA matching is especially punitive to blacks, since matching for broad DR specificities in black recipients does not necessarily match for subtypes unique to blacks. Modifying or de-emphasizing the UNOS point system for organ allocation based on MHC antigen should be seriously considered as a mechanism for increasing the percentage of black kidney transplant recipients.
authors.affiliation: Department of Surgery, St Louis University Medical Center, MO 63110-0250.
authors.forename: W
authors.initials: W
authors.lastname: Ross
authors.forename: H
authors.initials: H
authors.lastname: Solomon
authors.forename: J
authors.initials: J
authors.lastname: Reese
authors.forename: R
authors.initials: R
authors.lastname: Fairchild
authors.forename: P
authors.initials: P
authors.lastname: Garvin
authors.forename: M
authors.initials: M
authors.lastname: Kurtz
mesh_terms: D000328:Adult; D044383:Black People / Q000235:genetics*; D001803:Blood Transfusion; D003928:Diabetic Nephropathies / Q000601:surgery; D005260:Female; D015870:Gene Expression; D006084:Graft Rejection / Q000453:epidemiology / Q000276:immunology; D006085:Graft Survival / Q000276:immunology*; D015803:HLA-DR3 Antigen / Q000096:biosynthesis / Q000235:genetics*; D006650:Histocompatibility Testing; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D007676:Kidney Failure, Chronic / Q000601:surgery; D016030:Kidney Transplantation / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D014184:Transplantation, Homologous / Q000276:immunology; D044465:White People / Q000235:genetics*
chemical_list: D015803:HLA-DR3 Antigen